Do you need an office visit at Comprehensive Breast Care?
We have provided the following recommendations for our patients who are not sure if they need a face-to-face office visit during the COVID-19 pandemic. These are designed for your health and safety.
Recommendations are broken into the following priority categories based on patient condition:
Priority A: the patient’s condition is immediately life-threatening or clinically unstable; we will see these patients in the office
Priority B: the patient’s condition is non-critical but a delay beyond six to eight weeks potentially could impact the patient’s overall outcome; we will conduct a telemedicine visit to determine next best steps for the patient
Priority C: the patient’s condition is stable enough that services can be delayed for the duration of the COVID-19 pandemic; we will conduct telemedicine visits as needed
Priorities for breast disease focused outpatient visits
Priority A | Priority B | Priority C |
Potentially unstable (eg, hematoma, infection) | New diagnosis of noninvasive
cancer – convert as many visits to telemedicine visits |
Established patients with no new issues |
New diagnosis of invasive cancer – may convert to
telemedicine visit |
Post op patients | Survivorship visits |
Established patients with new problems or symptoms from treatment – convert as many visits to telemedicine visits | Patients at high risk for breast cancer (eg, BRCA carriers) | |
Well breast visits | ||
Benign breast follow up visits (including atypia and other
benign lesions) |
Priorities for breast disease focused imaging
Priority A | Priority B | Priority C |
None | Diagnostic imaging for breast symptoms or a BIRADS 4-5 screening mammogram | Routine screening can be deferred until the COVID-19 pandemic resolves. Patients in the general population can defer their screening mammography for 6 to 12 months; deferral will not likely impact overall survival |
Biopsies for abnormal mammograms or breast symptoms | Patients with abnormal screening mammograms who can go to 6 month interval imaging | |
Defer all screening with other
modalities such as MRI or breast U/S |